ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,945
0,22%
Bitcoin
63 806,07
-0,14%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. LivaNova PLC (LIVN)

  7. LivaNova PLC (LIVN) Actualités

LIVN LivaNova PLC

64,15
1,23 (1,95%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
LivaNova PLC LIVN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,23 1,95% 64,15 23:52:09
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
63,44 62,23 64,36 64,15 62,92
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202412:00BWLivaNova Reports First-Quarter 2024 Results
30/4/202415:00BWLivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation..
25/4/202422:03BWLivaNova Issues Notice to U.S. Patients Regarding..
21/3/202414:00BWLivaNova to Announce First-Quarter 2024 Results
20/3/202414:00BWLivaNova Announces a Positive Predictive Outcome of Trial..
11/3/202421:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202403:55EDGAR2Form 8-K - Current report
06/3/202403:55BWLivaNova Announces Pricing of Private Offering of $300..
04/3/202423:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/3/202423:22EDGAR2Form 8-K - Current report
04/3/202422:44BWLivaNova Announces Proposed Private Offering of $300 Million..
04/3/202415:00BWLivaNova to Present at the Barclays Global Healthcare..
29/2/202419:26EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
29/2/202419:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202412:03EDGAR2Form 8-K - Current report
21/2/202412:00BWLivaNova Reports Fourth-Quarter and Full-Year 2023 Results
05/2/202414:11EDGAR2Form 8-K - Current report
05/2/202414:00BWLivaNova Announces Vladimir A. Makatsaria as CEO and Board..
08/1/202414:32EDGAR2Form 8-K - Current report
08/1/202414:30BWLivaNova to Wind Down Advanced Circulatory Support Business..
04/1/202415:00BWLivaNova to Announce Fourth-Quarter and Full-Year 2023..
19/12/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202314:30EDGAR2Form 8-K - Current report
06/12/202313:00EDGAR2Form 8-K - Current report
20/11/202323:15EDGAR2Form 8-K - Current report
09/11/202315:00BWLivaNova to Present at the Piper Sandler Healthcare..
01/11/202320:03EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
01/11/202320:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202311:05EDGAR2Form 8-K - Current report
01/11/202311:00BWLivaNova Reports Third-Quarter 2023 Results
25/10/202315:00BWLivaNova to Present at the Stifel and Wolfe Healthcare..
19/10/202322:09EDGAR2Form 8-K - Current report
13/10/202322:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/10/202314:41EDGAR2Form 8-K - Current report
06/10/202314:30BWLivaNova Board Appoints J. Christopher Barry as New Director
21/9/202322:20EDGAR2Form 8-K/A - Current report: [Amend]
21/9/202313:09EDGAR2Form 8-K - Current report
21/9/202313:00BWLivaNova Announces Marco Dolci, President of..
20/9/202315:00BWLivaNova to Announce Third-Quarter 2023 Results
19/9/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202322:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202300:57BWLivaNova präsentiert Essenz In-Line Blood Monitor mit U.S...
31/8/202300:39BWLivaNova dévoile son moniteur de sang en ligne Essenz, qui..
30/8/202322:05BWLivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA..
24/8/202315:00BWLivaNova to Present at the Baird Global Healthcare..
26/7/202321:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/7/202321:24EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
26/7/202321:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/7/202312:05EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
LIVN
LivaNova
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés